BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22829239)

  • 1. Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.
    Neumann M; Heesch S; Gökbuget N; Schwartz S; Schlee C; Benlasfer O; Farhadi-Sartangi N; Thibaut J; Burmeister T; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
    Blood Cancer J; 2012 Jan; 2(1):e55. PubMed ID: 22829239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.
    Neumann M; Coskun E; Fransecky L; Mochmann LH; Bartram I; Sartangi NF; Heesch S; Gökbuget N; Schwartz S; Brandts C; Schlee C; Haas R; Dührsen U; Griesshammer M; Döhner H; Ehninger G; Burmeister T; Blau O; Thiel E; Hoelzer D; Hofmann WK; Baldus CD
    PLoS One; 2013; 8(1):e53190. PubMed ID: 23359050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical and Molecular Characteristics of FLT3 Mutations in Chinese De Novo Adolescent and Adult Acute Lymphoblastic Leukemia Patients.
    Shen Z; Chu XL; Wang RX; Li JL; Liu MY; Xie YY; Wang C; Han R; Yu JQ; Wang J; Tao T; Shen HJ; Chen SN; Wu DP; Qiu QC; Liu SB; Xue SL
    Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):e259-e269. PubMed ID: 32173273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD).
    Lo Nigro L; Andriano N; Buldini B; Silvestri D; Villa T; Locatelli F; Parasole R; Barisone E; Testi AM; Biondi A; Valsecchi MG; Rizzari C; Conter V; Basso G; Cazzaniga G
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
    Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
    Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
    Bond J; Graux C; Lhermitte L; Lara D; Cluzeau T; Leguay T; Cieslak A; Trinquand A; Pastoret C; Belhocine M; Spicuglia S; Lheritier V; Leprêtre S; Thomas X; Huguet F; Ifrah N; Dombret H; Macintyre E; Boissel N; Asnafi V
    J Clin Oncol; 2017 Aug; 35(23):2683-2691. PubMed ID: 28605290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia.
    Baldus CD; Thibaut J; Goekbuget N; Stroux A; Schlee C; Mossner M; Burmeister T; Schwartz S; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
    Haematologica; 2009 Oct; 94(10):1383-90. PubMed ID: 19794083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia.
    Noronha EP; Marques LVC; Andrade FG; Thuler LCS; Terra-Granado E; Pombo-de-Oliveira MS;
    Front Oncol; 2019; 9():316. PubMed ID: 31338319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations.
    Neumann M; Heesch S; Schlee C; Schwartz S; Gökbuget N; Hoelzer D; Konstandin NP; Ksienzyk B; Vosberg S; Graf A; Krebs S; Blum H; Raff T; Brüggemann M; Hofmann WK; Hecht J; Bohlander SK; Greif PA; Baldus CD
    Blood; 2013 Jun; 121(23):4749-52. PubMed ID: 23603912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical study of allogeneic hematopoietic stem cell transplantation in 23 patients with early T-cell precursor acute lymphoblastic leukemia].
    Zhu YX; Zhu MQ; Dai HP; Liu SN; Yin J; Li Z; Cui QY; Zhu XM; Wu DP; Tang XW
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1021-1025. PubMed ID: 32023734
    [No Abstract]   [Full Text] [Related]  

  • 11. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
    Jain N; Lamb AV; O'Brien S; Ravandi F; Konopleva M; Jabbour E; Zuo Z; Jorgensen J; Lin P; Pierce S; Thomas D; Rytting M; Borthakur G; Kadia T; Cortes J; Kantarjian HM; Khoury JD
    Blood; 2016 Apr; 127(15):1863-9. PubMed ID: 26747249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL.
    Fransecky L; Neumann M; Heesch S; Schlee C; Ortiz-Tanchez J; Heller S; Mossner M; Schwartz S; Mochmann LH; Isaakidis K; Bastian L; Kees UR; Herold T; Spiekermann K; Gökbuget N; Baldus CD
    J Hematol Oncol; 2016 Sep; 9(1):95. PubMed ID: 27658391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia.
    Ma M; Wang X; Tang J; Xue H; Chen J; Pan C; Jiang H; Shen S
    Front Med; 2012 Dec; 6(4):416-20. PubMed ID: 23065427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated clinical genotype-phenotype characteristics of early T-cell precursor acute lymphoblastic leukemia.
    Ye MT; Wang Y; Zuo Z; Calin S; He H; Tang Z; Jabbour EJ; Borthakur G; Zhang Y; Yang Y; You MJ
    Cancer; 2023 Jan; 129(1):49-59. PubMed ID: 36281717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
    Mao J; Xue L; Wang H; Zhu Y; Wang J; Zhao L
    Onco Targets Ther; 2021; 14():3795-3802. PubMed ID: 34168464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early T-cell precursor acute lymphoblastic leukemia with
    Tran T; Krause J
    Proc (Bayl Univ Med Cent); 2018 Oct; 31(4):511-513. PubMed ID: 30948995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.
    Xu X; Paxton CN; Hayashi RJ; Dunsmore KP; Winter SS; Hunger SP; Winick NJ; Carroll WL; Loh ML; Devidas M; Gross TG; Bollard CM; Perkins SL; Miles RR
    Blood Adv; 2021 Jul; 5(14):2890-2900. PubMed ID: 34297047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early T-cell precursor acute lymphoblastic leukemia and other subtypes: a retrospective case report from a single pediatric center in China.
    Liu X; Zou Y; Zhang L; Chen X; Yang W; Guo Y; Chen Y; Zhang Y; Zhu X
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2775-2788. PubMed ID: 33651142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia.
    Zhang Y; Qian JJ; Zhou YL; Huang X; Li JH; Li XY; Li CY; Wang HP; Lou YJ; Meng HT; Yu WJ; Tong HY; Jin J; Zhu HH
    Front Oncol; 2020; 10():1423. PubMed ID: 32974153
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
    Morita K; Jain N; Kantarjian H; Takahashi K; Fang H; Konopleva M; El Hussein S; Wang F; Short NJ; Maiti A; Sasaki K; Garcia-Manero G; Konoplev S; Ravandi F; Khoury JD; Jabbour E
    Am J Hematol; 2021 May; 96(5):589-598. PubMed ID: 33639000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.